Nutri-PEITC Jelly Significantly Improves Progression-Free Survival and Quality of Life in Patients with Advanced Oral and Oropharyngeal Cancer: A Blinded Randomized Placebo-Controlled Trial
TP53 mutation is associated with cancer progression. Novel strategies to reboot p53 are required to stabilize the disease and improve survival. This randomized placebo-controlled trial investigated safety and efficacy of Nutri-PEITC Jelly (a texture-modified nutritious diet fortified with β-phenethy...
Saved in:
Main Author: | Lam-Ubol A. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82826 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Nutri-jelly may improve quality of life and decrease tube feeding demand in head and neck cancer patients
by: Dunyaporn Trachootham, et al.
Published: (2018) -
Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma
by: Chow, P.K.H., et al.
Published: (2014) -
Effects of Oral Procaterol for Postinfectious Cough in Adults: Single- Centre, Randomized Double-Blind, Placebo-Controlled Trial
by: Prapaporn Pornsuriyasak, et al.
Published: (2022) -
Blinded, placebo-controlled trial of antiparasitic drugs for trichinosis myositis
by: George Watt, et al.
Published: (2018) -
Immune-associated plasma proteins in oral and oropharyngeal cancer patients
by: Buranapraditkun S.
Published: (2023)